Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection.
Acinetobacter
intraperitoneal infection
porcine mucin
virulence
Journal
Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
01
08
2019
accepted:
07
08
2019
pubmed:
14
8
2019
medline:
14
1
2020
entrez:
14
8
2019
Statut:
epublish
Résumé
Porcine mucin has been commonly used to enhance the infectivity of bacterial pathogens, including
Identifiants
pubmed: 31405959
pii: IAI.00591-19
doi: 10.1128/IAI.00591-19
pmc: PMC6803341
pii:
doi:
Substances chimiques
Mucins
0
Recombinant Proteins
0
Interleukin-10
130068-27-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Crown copyright 2019.
Références
Microbes Infect. 2009 Oct;11(12):946-55
pubmed: 19573619
J Antimicrob Chemother. 1985 Apr;15(4):441-8
pubmed: 4008377
Bacteriol Rev. 1948 Jun;12(2):149-72
pubmed: 16350119
J Antimicrob Chemother. 2012 Jun;67(6):1439-45
pubmed: 22389456
Infect Chemother. 2017 Mar;49(1):57-61
pubmed: 28271653
Infect Immun. 1980 Sep;29(3):886-91
pubmed: 6159328
Antimicrob Agents Chemother. 2013 Aug;57(8):3601-13
pubmed: 23689726
J Infect Dis. 2017 Feb 15;215(suppl_1):S52-S57
pubmed: 28375520
Medchemcomm. 2018 Jun 18;9(7):1206-1212
pubmed: 30109009
Infect Immun. 2019 Mar 25;87(4):
pubmed: 30745328
Vaccine. 2017 Mar 7;35(10):1440-1447
pubmed: 28190743
Infect Immun. 1979 May;24(2):545-51
pubmed: 110703
Infect Immun. 2009 Mar;77(3):1015-21
pubmed: 19103777
Clin Microbiol Rev. 2008 Jul;21(3):538-82
pubmed: 18625687
J Infect Dis. 2006 Jan 15;193(2):187-95
pubmed: 16362882
Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1391-8
pubmed: 21479973
Infect Immun. 2007 Dec;75(12):5597-608
pubmed: 17908807
Virulence. 2013 Aug 15;4(6):467-72
pubmed: 23863607
Int J Med Microbiol. 2014 May;304(3-4):360-9
pubmed: 24440358
Infect Immun. 2011 Aug;79(8):3317-27
pubmed: 21576323
Infect Immun. 1980 Feb;27(2):449-54
pubmed: 6155334
Cell Host Microbe. 2013 May 15;13(5):509-519
pubmed: 23684303
New Microbiol. 2015 Jan;38(1):67-73
pubmed: 25742149
Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8676-80
pubmed: 1528880
Br J Exp Pathol. 1952 Aug;33(4):327-39
pubmed: 14954104
PLoS One. 2018 Jan 8;13(1):e0190599
pubmed: 29309434
Infect Immun. 2011 Jan;79(1):518-26
pubmed: 20974823
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9599-604
pubmed: 27506797
Antimicrob Agents Chemother. 2019 Aug 23;63(9):
pubmed: 31209004
Vaccine. 2011 Aug 5;29(34):5705-10
pubmed: 21679737
Int Immunopharmacol. 2011 Sep;11(9):1378-83
pubmed: 21496497
Can J Microbiol. 1959 Feb;5(1):73-7
pubmed: 13629387
J Bacteriol. 1958 Dec;76(6):631-9
pubmed: 13610801
Front Immunol. 2017 Apr 12;8:441
pubmed: 28446911
Clin Microbiol Rev. 2017 Jan;30(1):409-447
pubmed: 27974412
J Clin Microbiol. 2008 Aug;46(8):2499-507
pubmed: 18524965
Curr Protoc Microbiol. 2017 Aug 11;46:6G.3.1-6G.3.23
pubmed: 28800159
FEMS Microbiol Rev. 2013 Mar;37(2):130-55
pubmed: 22568581
PLoS One. 2014 Jun 23;9(6):e100727
pubmed: 24956279
Can J Microbiol. 1976 Jun;22(6):832-8
pubmed: 819118
Clin Microbiol Infect. 2007 Feb;13(2):196-198
pubmed: 17328733
Int J Infect Dis. 2012 Jan;16(1):e34-40
pubmed: 22088863
Br J Exp Pathol. 1954 Dec;35(6):528-38
pubmed: 13230409
Biopolymers. 2011;96(2):126-9
pubmed: 20564029
Infect Immun. 2019 Mar 25;87(4):
pubmed: 30718286
Sci Rep. 2019 Apr 25;9(1):6538
pubmed: 31024025
Antimicrob Agents Chemother. 1997 Feb;41(2):345-51
pubmed: 9021190
Infect Immun. 2012 Oct;80(10):3381-8
pubmed: 22825448
J Infect Dis. 2015 Apr 15;211(8):1296-305
pubmed: 25378635
Infect Immun. 2017 Feb 23;85(3):
pubmed: 28052995
Antimicrob Agents Chemother. 2012 Oct;56(10):5397-400
pubmed: 22825117
Am J Respir Crit Care Med. 2006 Jan 1;173(1):122-9
pubmed: 16210672
PLoS One. 2012;7(6):e40019
pubmed: 22768201